RAPT Therapeutics, Inc. (RAPT) Profit After Tax (2020 - 2024)
RAPT Therapeutics' Profit After Tax history spans 5 years, with the latest figure at -$53.2 million for Q4 2024.
- For Q4 2024, Profit After Tax fell 72.46% year-over-year to -$53.2 million; the TTM value through Dec 2024 reached -$129.9 million, down 11.19%, while the annual FY2024 figure was -$129.9 million, 11.19% down from the prior year.
- Profit After Tax for Q4 2024 was -$53.2 million at RAPT Therapeutics, down from -$18.4 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$12.4 million in Q2 2020 and bottomed at -$53.2 million in Q4 2024.
- The 5-year median for Profit After Tax is -$19.8 million (2022), against an average of -$22.6 million.
- The largest YoY upside for Profit After Tax was 41.25% in 2024 against a maximum downside of 72.46% in 2024.
- A 5-year view of Profit After Tax shows it stood at -$12.7 million in 2020, then crashed by 40.79% to -$17.9 million in 2021, then decreased by 28.01% to -$23.0 million in 2022, then crashed by 34.53% to -$30.9 million in 2023, then crashed by 72.46% to -$53.2 million in 2024.
- Per Business Quant, the three most recent readings for RAPT's Profit After Tax are -$53.2 million (Q4 2024), -$18.4 million (Q3 2024), and -$27.7 million (Q2 2024).